Contract21 Consulting Agreement • May 5th, 2020 • Washington
EX-10.21 3 exhibit10-21.htm EXHIBIT 10.21 CONSULTING AGREEMENT This Consulting Agreement ("Agreement"), effective as of January 4, 2016 ("Effective Date"), is made by and between Emergent Product Development Seattle, LLC ("Emergent"), having its principal office at 2401 4th Avenue, Suite 1050, Seattle, Washington 98121, and Barry A. Labinger ("Consultant"), having his principal office at ********************************. Emergent and Consultant are hereinafter referred to individually as "Party" or collectively as the "Parties". The Parties hereby agree as follows: WHEREAS, Emergent BioSolutions Inc. plans to spin-off its biosciences business (the "Spin-off") to create a separate public company ("Aptevo"). WHEREAS, Emergent desires to retain the services of Consultant to provide strategy, advice and guidance in connection with the planned Spin-off and the business activities of Aptevo following the Spin-off. NOW, THEREFORE, in consideration of the foregoing and subject to the covenants
